Display options
Share it on

Transfus Med Hemother. 2013 Jun;40(3):182-9. doi: 10.1159/000351459. Epub 2013 May 08.

Luminex(®) and its applications for solid organ transplantation, hematopoietic stem cell transplantation, and transfusion.

Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie

Nils Lachmann, Kremena Todorova, Harald Schulze, Constanze Schönemann

Affiliations

  1. Center for Tumor Medicine, Charité-Universitätsmedizin Berlin - Campus Virchow-Klinikum, Berlin, Germany ; ZTB Zentrum für Transfusionsmedizin und Zelltherapie Berlin, HLA Tissue Typing Laboratory, Berlin, Germany.

PMID: 23922543 PMCID: PMC3725018 DOI: 10.1159/000351459

Abstract

SUMMARY: The detection of antibodies against the human leukocyte antigen (HLA) complex has become indispensable in every clinical practice. The development of solid-phase assays like the Luminex allows the standardized measurement of anti-HLA antibodies (HLAab) with high sensitivity, albeit the relevance for some clinical settings remains a matter of debate. In this review we aim to describe the principle of Luminex-based antibody detection, including two modifications that allow identifying solely complement-activating antibodies. We then describe three applications for Luminex: i) detection of HLAab preceding solid-organ transplantation and monitoring of donor-specific antibodies posttransplant as a risk factor for antibody-mediated rejection; ii) presence of HLAab in recipients as a risk for graft failure in hematopoietic stem cell transplantation, especially in haploidentical or mismatched transplantations; iii) role of HLAab in blood transfusion including refractory thrombocytopenia and selection of suitable platelet donors, transfusion-related lung injury after plasma transfusion, and immunization against HLA after red blood cell transfusion despite leukodepletion. Although the Luminex platform constitutes a potent technology for HLA antibody detection, some drawbacks require the well-educated analysis and interpretation of data in critical cases. In addition, Luminex has become an important tool to identify clinically relevant antibodies.

Keywords: HLA antibodies; Luminex; Transfusion

References

  1. Transfus Med Rev. 2005 Jan;19(1):2-31 - PubMed
  2. Hum Immunol. 2007 Sep;68(9):779-88 - PubMed
  3. Blood. 2011 Apr 21;117(16):4218-25 - PubMed
  4. Hum Immunol. 2009 Oct;70(10):844-53 - PubMed
  5. Biomark Med. 2008 Dec;2(6):603-12 - PubMed
  6. Transplantation. 1965 Nov;3(6):701-5 - PubMed
  7. Br J Haematol. 2008 Jul;142(3):348-60 - PubMed
  8. Transplantation. 2008 Apr 15;85(7):1046-50 - PubMed
  9. Transfusion. 2012 Mar;52(3):567-74 - PubMed
  10. Tissue Antigens. 2009 Aug;74(2):101-16 - PubMed
  11. Methods Mol Biol. 2012;882:289-308 - PubMed
  12. Nature. 1958 Jun 21;181(4625):1735-6 - PubMed
  13. Hum Immunol. 2010 Jan;71(1):45-9 - PubMed
  14. Am J Transplant. 2012 May;12(5):1192-8 - PubMed
  15. Vox Sang. 2012 Jul;103(1):10-7 - PubMed
  16. Transplantation. 2009 Oct 27;88(8):1019-24 - PubMed
  17. Am J Transplant. 2003 Jun;3(6):665-73 - PubMed
  18. Nephrol Dial Transplant. 2012 Mar;27(3):1246-51 - PubMed
  19. Tissue Antigens. 2011 Jul;78(1):1-7 - PubMed
  20. Am J Transplant. 2012 Feb;12(2):388-99 - PubMed
  21. Histol Histopathol. 2006 Oct;21(10):1115-24 - PubMed
  22. Crit Care Med. 2010 Feb;38(2):546-52 - PubMed
  23. Tissue Antigens. 2013 Jan;81(1):1-11 - PubMed
  24. Am J Transplant. 2004 Mar;4(3):378-83 - PubMed
  25. Transfusion. 1986 Jul-Aug;26(4):375-81 - PubMed
  26. Am J Transplant. 2011 Sep;11(9):1785-91 - PubMed
  27. Transfusion. 2012 Oct;52(10):2146-54 - PubMed
  28. Vox Sang. 1994;66(3):200-5 - PubMed
  29. Curr Pharm Des. 2012;18(22):3241-8 - PubMed
  30. N Engl J Med. 1969 Apr 3;280(14):735-9 - PubMed
  31. Am J Transplant. 2012 Jun;12(6):1618-23 - PubMed
  32. Vox Sang. 2005 Jul;89(1):1-10 - PubMed
  33. Clin J Am Soc Nephrol. 2013 May;8(5):852-60 - PubMed
  34. Transplantation. 2009 Mar 27;87(6):813-20 - PubMed
  35. Transplantation. 2012 Dec 15;94(11):1111-6 - PubMed
  36. Transplantation. 2008 Oct 27;86(8):1111-5 - PubMed
  37. Tissue Antigens. 1985 Jul;26(1):12-9 - PubMed
  38. Hum Immunol. 2001 Oct;62(10):1178-84 - PubMed
  39. Int J Immunogenet. 2013 Feb;40(1):17-20 - PubMed
  40. Bone Marrow Transplant. 2012 Apr;47(4):508-15 - PubMed
  41. Bone Marrow Transplant. 2012 Oct;47(10):1338-42 - PubMed
  42. Transfus Med. 2010 Apr;20(2):95-103 - PubMed
  43. Transplantation. 2011 Jul 15;92(1):41-7 - PubMed
  44. Blood. 2012 Oct 4;120(14):2918-24 - PubMed
  45. N Engl J Med. 1997 Dec 25;337(26):1861-9 - PubMed
  46. Curr Opin Organ Transplant. 2012 Aug;17(4):409-15 - PubMed
  47. J Heart Lung Transplant. 2011 Feb;30(2):158-63 - PubMed
  48. Hum Immunol. 2009 Jul;70(7):496-501 - PubMed
  49. Acta Haematol. 1958 Jul-Oct;20(1-4):156-66 - PubMed
  50. Clin Chem. 2000 Oct;46(10):1719-21 - PubMed
  51. Transplantation. 2013 Jan 15;95(1):19-47 - PubMed
  52. N Engl J Med. 2004 Dec 23;351(26):2715-29 - PubMed
  53. Am J Transplant. 2007 Dec;7(12):2809-15 - PubMed
  54. Ann Clin Lab Sci. 2006 Winter;36(1):53-8 - PubMed
  55. Transfusion. 2011 Dec;51(12):2611-8 - PubMed
  56. Transplant Proc. 2012 Jan;44(1):222-5 - PubMed
  57. Am J Transplant. 2007 Apr;7(4):1027-31 - PubMed
  58. Hum Immunol. 2005 May;66(5):526-34 - PubMed
  59. Int J Immunogenet. 2013 Jun;40(3):171-7 - PubMed
  60. J Clin Invest. 1977 Apr;59(4):625-32 - PubMed
  61. Transplantation. 2011 Sep 15;92(5):510-5 - PubMed
  62. Transpl Int. 2009 Oct;22(10):982-9 - PubMed
  63. Vox Sang. 1998;74 Suppl 2:359-63 - PubMed
  64. Hum Immunol. 2009 Aug;70(8):563-8 - PubMed
  65. Transplantation. 2013 Mar 15;95(5):694-700 - PubMed
  66. J Exp Med. 1995 Jun 1;181(6):2085-95 - PubMed

Publication Types